Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Bill Haddad

1664 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Asset Sales
  • News

Avient Signs Agreement To Divest Distribution Business To H.I.G. Capital For $950M

By Bill Haddad
August 12, 6:47 AM
CLEVELAND, Aug. 12, 2022 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), a leading global provider of sustainable and specialized material solutions, today announced it has entered into a definitive agreement

AVNT

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

Pfizer Announces Top-Line Results From Phase 3 Study Of 20-Valent Pneumococcal Conjugate Vaccine In Infants; Says 20vPnC Demonstrated Favorable Safety And Tolerability Profile

By Bill Haddad
August 12, 6:46 AM
Pivotal top-line data demonstrate a four-dose series of 20-valent pneumococcal conjugate vaccine candidate (20vPnC), if approved, would provide the broadest serotype coverage of any pneumococcal conjugate vaccine in

PFE

Read More
1 minute read
  • Earnings
  • News

Spectrum Brands Holdings Q3 EPS $0.54 Down From $0.72 YoY, Sales $818.00M Miss $917.88M Estimate

By Bill Haddad
August 12, 6:33 AM
Spectrum Brands Holdings (NYSE:SPB) reported quarterly earnings of $0.54 per share. This is a 25 percent decrease over earnings of $0.72 per share from the same period last year. The company reported quarterly sales of

SPB

Read More
3 minute read
  • General

Fisker Says Sold Out Of 2023 US Allotment Of Fisker Ocean Sport And Fisker Ocean Ultra Trim Levels

By Bill Haddad
August 12, 6:31 AM
Fisker Inc. sold out of its 2023 US allotment of the Fisker Ocean Sport and Fisker Ocean Ultra trim levels. Last month, the company also sold out its 5,000 Fisker Ocean One launch edition globally, with buyers in nine

FSR

Read More
1 minute read
  • Earnings
  • News

Mannatech Q2 EPS $0.34 Down From $0.99 YoY, Sales $35.00M Down From $42.50M YoY

By Bill Haddad
August 12, 6:19 AM
Mannatech (NASDAQ:MTEX) reported quarterly earnings of $0.34 per share. This is a 65.66 percent decrease over earnings of $0.99 per share from the same period last year. The company reported $35.00 million in sales this

MTEX

Read More
1 minute read
  • Management
  • News

Harsco CFO Anshooman Aga To Resign, Pete Minan Appointed CFO

By Bill Haddad
August 12, 6:18 AM
Harsco Corporation (NYSE:HSC) a global, market leading provider of environmental solutions for industrial and specialty waste streams, today announced that Anshooman Aga has resigned as the Company's Senior Vice

HSC

Read More
1 minute read
  • Earnings
  • News

Barnwell Industries Q3 EPS $0.59, Same YoY, Sales $8.03M Up From $5.11M YoY

By Bill Haddad
August 12, 6:11 AM
Barnwell Industries (AMEX:BRN) reported quarterly earnings of $0.59 per share. This is unchanged from the same period last year. The company reported $8.03 million in sales this quarter. This is a 56.98 percent increase

BRN

Read More
1 minute read
  • Guidance
  • News

AirSculpt Technologies Reaffirms FY22 Guidance

By Bill Haddad
August 12, 6:06 AM
2022 Outlook The Company is reiterating its revenue outlook of $175-179 million and its Adjusted EBITDA guidance in the range of $58 - $60 million. The Company has opened two

AIRS

Read More
1 minute read
  • Earnings
  • News

Chemomab Therapeutics Q2 EPS $(0.03) Beats $(0.25) Estimate

By Bill Haddad
August 12, 6:03 AM
Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.25) by 88 percent. This is a 88.46 percent increase over losses of $(0.26) per share

CMMB

Read More
1 minute read
  • Earnings
  • News

China Automotive Systems Q2 EPS $0.31 Beats $(0.05) Estimate, Sales $127.20M Beat $104.39M Estimate

By Bill Haddad
August 12, 6:02 AM
China Automotive Systems (NASDAQ:CAAS) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $(0.05) by 720 percent. This is a 210 percent increase over earnings of $0.10 per share

CAAS

Posts pagination

Previous 1 … 105 106 107 … 167 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service